Market data not licensed for redistribution.

Genexine

095700 · KOSDAQ · R&D in Natural Sciences & Engineering

– Previous close pending (official data.go.kr feed not active yet) Live price ↗

Source: Financial Services Commission stock price data (data.go.kr), updated once a day.

Daily price, 1 year

Key statistics

Market cap (KRW bn)–

PER–

PBR–

ROE %–

Debt ratio % (liabilities / equity)–

Revenue TTM (KRW bn)–

Op. profit TTM (KRW bn)–

Dividend yield %–

Basis: market cap at …; equity = total equity (consolidated if available) at –; net income = trailing 12 months to – (consolidated). PER is not shown when TTM net income is negative.

Upcoming risk events

Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.

No scheduled risk events found (last checked 2026-10-30 19:40 KST).

Other scheduled dates (routine, not risks) (1)

2026-11-20 · Routine schedule: extraordinary shareholder meeting

See it in the full calendar →

Annual results (KRW bn)

	2021	2022	2023	2024	2025
Revenue	36.8	16.1	4.4	–	–
Operating profit	-19.4	-33.7	-41.2	–	–
Net income	-48.9	-56.8	-66.9	–	–

Quarterly results (KRW bn, 3 months)

	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	–	–	–	–	–	–
Operating profit	–	–	–	–	–	–
Net income	–	–	–	–	–	–

Largest shareholder

As of the 2025 annual report: (주)한독 and related parties hold 13.28% of common shares.

Recent disclosures

Date	Filing
2026-10-26	Withdrawal of filing 기타주요경영사항 (유상증자결정(제3자배정-소액공모) 철회)	DART original
2026-10-26	Securities registration / prospectus 소액공모실적보고서	DART original
2026-10-26	Securities registration / prospectus [기재정정]소액공모공시서류(지분증권)	DART original
2026-10-26	Rights offering (paid-in capital increase) [기재정정]주요사항보고서(유상증자결정)	DART original
2026-10-16	Securities registration / prospectus 소액공모공시서류(지분증권)	DART original
2026-10-16	Rights offering (paid-in capital increase) 주요사항보고서(유상증자결정)	DART original
2026-10-06	Shareholder meeting 주주명부폐쇄기간또는기준일설정	DART original
2026-10-06	Shareholder meeting 주주총회소집결의 (임시주주총회)	DART original
2026-08-24	Governance / misc. (routine) 주식매수선택권부여에관한신고	DART original
2026-08-21	Other material event (investment-relevant) 투자판단관련주요경영사항 (GXI7 관련 마일스톤 기술료 청구)	DART original
2026-08-13	Periodic report (annual/half/quarterly) 반기보고서 (2026.06)	DART original
2026-07-03	Debt guarantee / collateral for others 타인에대한담보제공결정	DART original

Past material filings and price reaction (market-adjusted)

Date	Filing type	On the news (vs. market)	Next day (vs. market)	20 days (vs. market)
2026-08-21	Other material event (investment-relevant)	+15.5%	-6.7%	-15.9%
2026-06-04	Clinical trial / regulatory approval	+0.5%	-0.3%	-12.8%
2026-04-15	Litigation	+25.2%	+1.7%	-23.5%
2026-02-02	Revenue/profit change >=30% (15% large caps)	-2.6%	-2.8%	+2.9%
2025-12-09	Clinical trial / regulatory approval	+0.3%	-1.9%	-13.8%
2025-09-24	Convertible bond issuance	+0.7%	-1.0%	-5.8%
2025-08-20	Other material event (investment-relevant)	+2.1%	+0.9%	-0.6%
2025-02-26	Clinical trial / regulatory approval	-0.8%	-0.3%	+2.3%
2025-02-06	Revenue/profit change >=30% (15% large caps)	-0.8%	-1.3%	-7.3%
2024-11-14	Clinical trial / regulatory approval	-0.8%	-1.9%	-9.8%

For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view